Skip to Content

Biostar Pharmaceuticals Inc BSPM

Morningstar Rating
$0.00 −0.01 (98.95%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BSPM is trading at a 31% discount.
Price
$0.00
Fair Value
$9.60
Uncertainty
Extreme
1-Star Price
$5.22
5-Star Price
$9.54
Economic Moat
Jrtjs
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BSPM is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.01
Day Range
$0.000.00
52-Week Range
$0.000.01
Bid/Ask
$0.01 / $0.10
Market Cap
$263.72
Volume/Avg
9,427 / 2,533

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
200

Valuation

Metric
BSPM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
BSPM

Financial Strength

Metric
BSPM
Quick Ratio
0.16
Current Ratio
0.19
Interest Coverage
18.81
Quick Ratio
BSPM

Profitability

Metric
BSPM
Return on Assets (Normalized)
1.58%
Return on Equity (Normalized)
1.83%
Return on Invested Capital (Normalized)
2.02%
Return on Assets
BSPM
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class APfc$90.0 Bil
MKKGY
Merck KGaA ADRVbrtrcv$72.2 Bil
HLN
Haleon PLC ADRLshwp$37.8 Bil
VTRS
Viatris IncRcqhd$16.0 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRQylgt$14.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRWptz$12.8 Bil
CTLT
Catalent IncTcldmcl$10.6 Bil
PRGO
Perrigo Co PLCMvg$4.3 Bil
CURLF
Curaleaf Holdings IncQmvd$3.8 Bil
PBH
Prestige Consumer Healthcare IncPbsvvb$3.4 Bil

Sponsor Center